88617127 - CYCAT

Information

  • Trademark
  • 88617127
  • Serial Number
    88617127
  • Registration Number
    6156664
  • Filing Date
    September 14, 2019
    4 years ago
  • Registration Date
    September 22, 2020
    3 years ago
  • Transaction Date
    September 22, 2020
    3 years ago
  • Status Date
    September 22, 2020
    3 years ago
  • Published for Opposition Date
    July 07, 2020
    3 years ago
  • Location Date
    September 22, 2020
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    POWERS, ALEXANDER L
  • Attorney Docket Number
    114353.00071
    Attorney Name
    Michael J. Leonard
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
4000
Mark Identification
CYCAT
Case File Statements
  • GS0011: Antibodies for scientific purposes and not for medical or veterinary use; Monoclonal antibodies for diagnostic use and not for medical or veterinary use; Biochemicals, namely, monoclonal antibodies for scientific or research use; Tagged antibodies for scientific and laboratory use; immunological antibodies not for medical use; Reagents for use in the development of monoclonal antibodies not for medical or veterinary purposes; biological and biotechnological products used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; biological preparations for laboratories, for diagnostics, and for analysis and environmental analysis, other than for medical or veterinary use
  • GS0051: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, autoimmune diseases, Alzheimer, sepsis, and restenosis; diagnostic antibodies for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, autoimmune diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, autoimmune diseases, Alzheimer, sepsis, and restenosis; biological preparations for medical and veterinary purposes, namely, antibodies sold as a component ingredient of pharmaceuticals
  • GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, autoimmune diseases, Alzheimer, sepsis, and restenosis; medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies
Case File Event Statements
  • 9/22/2020 - 3 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/7/2020 - 3 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/7/2020 - 3 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/17/2020 - 3 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/4/2020 - 3 years ago
    15 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 5/29/2020 - 3 years ago
    14 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 5/28/2020 - 3 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/27/2020 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/27/2020 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/25/2020 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/18/2019 - 4 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/18/2019 - 4 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/18/2019 - 4 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/15/2019 - 4 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/22/2019 - 4 years ago
    5 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED Type: AMPX
  • 11/21/2019 - 4 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 11/17/2019 - 4 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/23/2019 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/18/2019 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP